1. Optimizing the Pharmacologic Treatment of Hypertension

   • Peter M. Nilsson

   Current Opinion 20 August 2012 Pages: 287 - 295

   

2. Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure

   • David P. Macfarlane
   • Miles Fisher

   Current Opinion 20 August 2012 Pages: 297 - 304

   

3. Therapeutic Potential of Thymosin-β4 and its Derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in Cardiac Healing After Infarction

   • Maria A. Cavasin

   Current Opinion 20 August 2012 Pages: 305 - 311

   

4. Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention

   • Michael J. Lipinski
   • George W. Vetrovec

   Therapy In Practice 20 August 2012 Pages: 313 - 325

   

5. The ASCOT Trial

   • Philippe Meurin

   Review Article 20 August 2012 Pages: 327 - 334

   

6. The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study)

   • Ronald D. Smith
   • Hiroshi Yokoyama
   • Carlos M. Ferrario

   Original Research Article 20 August 2012 Pages: 335 - 342

   

7. The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome

   • Ergun Topal
   • Ayse Sertkaya Cikim
   • Ramazan Ozdemir

   Original Research Article 20 August 2012 Pages: 343 - 348

   

8. Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland

   • Evo Alemao
   • Don Yin
   • Pekka Jousilahti

   Original Research Article 20 August 2012 Pages: 349 - 355

   

9. Spotlight on Ranolazine in Chronic Stable Angina Pectoris

   • M. Asif A. Siddiqui
   • Susan J. Keam

   Adis Spotlight 20 August 2012 Pages: 357 - 359